Intrinsic Foundries, a carbon-to-value biomanufacturing platform transforming industrial carbon emissions into premium biochemicals, has raised ₹12 crore (~$1.4 million) in Seed funding led by Transition VC. The fresh capital will enable the company to execute industrial pilots, expand research initiatives, and strengthen its intellectual property portfolio. In addition, Intrinsic plans to scale its engineering and commercial teams, enhance manufacturing capabilities, and establish its U.S. entity to accelerate global market development.
Redefining Carbon Capture Economics
Traditionally, carbon capture has treated emissions as waste destined for underground storage—often costing tens of millions of dollars with little or no economic return. Intrinsic Foundries challenges this model. Instead of burying emissions, the company converts captured carbon into high-value biochemicals using nature’s most efficient biological systems. These biochemicals serve critical industries, including food, pharmaceuticals, nutraceuticals, cosmetics, agriculture, and advanced materials. As a result, emissions become valuable product inputs, creating new revenue streams for heavy industries.
A Factory 4.0-Enabled Carbon Biorefinery Platform
At the core of Intrinsic’s innovation is its proprietary carbon biorefinery platform. The system integrates:
*Advanced photobioreactor cultivation technology
*Microalgae-based carbon capture systems
*Factory 4.0 automation for industrial scalability
Currently, the company’s primary focus is on microalgae-based biorefineries designed to capture industrial carbon emissions efficiently. Simultaneously, it is developing additional microbial biorefineries, including yeast-based systems. Intrinsic successfully completed a Proof of Concept at a thermal power plant last year. The pilot demonstrated extended continuous carbon capture with strong operational reliability—validating both the technology and its industrial viability.
Building a Circular Carbon Economy
Shreyansh Jain, Founder of Intrinsic Foundries, emphasized, “Carbon is not waste. It is a resource waiting to be transformed. The economics of carbon capture have been broken for decades because the industry has been trying to bury the problem underground. At Intrinsic, we use nature-based biological systems to convert industrial emissions into ingredients used in supplements, food, and skincare. This funding accelerates our mission to build a circular carbon economy where heavy industries become suppliers to the health and wellness sector.”
He further highlighted the importance of decarbonizing hard-to-abate sectors such as steel, cement, refineries, and chemicals. While Carbon Capture, Utilisation, and Storage (CCUS) remains one of the few viable pathways for these industries, adoption has been constrained by high capex and weak unit economics.
Transition VC on the Investment Thesis
Shantanu Chaturvedi, Partner at Transition VC, noted that India’s commitment of ₹20,000 crore (~$2.4 billion) over five years toward scaling CCUS will accelerate adoption. “In the context of CCUS, adoption is constrained by unfavourable unit economics and higher capital expenditure costs. Intrinsic Foundries captures CO₂ using microalgae and converts it into high-value biochemicals for pharmaceutical, nutraceutical, and cosmetic industries. By utilising captured carbon, the platform generates revenue-positive outcomes. We believe Intrinsic is well-positioned to capture a significant share of this emerging market,” Chaturvedi mentioned.
Gaurav Patil, VP of Investments at Transition VC, highlighted, “For centuries, humanity has harnessed biological systems through fermentation and agriculture. However, scaling them for industrial use has been constrained by slow kinetics and environmental sensitivities. Intrinsic addresses these challenges through industrial-grade strain development and modular reactor architecture, enabling reliable and large-scale deployment.”
Growing Industrial Partnerships and Market Validation
Intrinsic Foundries is already advancing commercial engagements across multiple sectors, including:
*Cement
*Steel
*Pharmaceuticals
*Nutraceuticals
*Food systems
These partnerships validate both the technological feasibility and the growing market demand for revenue-positive carbon utilisation at industrial scale.
Roadmap: From Pilots to Commercial Scale
Over the next 12 to 24 months, Intrinsic plans to:
*Commission multiple industrial pilots
*Operationalize its first one-ton-per-day commercial plant
*Expand its patent portfolio
*Generate cumulative revenues from pilot projects and biochemical sales
Strengthen international market access
As per the press release, looking ahead, the company aims to position carbon-to-value biomanufacturing infrastructure as a foundational layer of global industrial decarbonisation. By doing so, Intrinsic seeks to demonstrate that emissions can power sustainable supply chains—while delivering measurable economic returns.
